Literature DB >> 3291600

Complex carbohydrates in the dietary management of patients with glycogenosis caused by glucose-6-phosphatase deficiency.

G P Smit1, M T Ververs, B Belderok, M Van Rijn, R Berger, J Fernandes.   

Abstract

Carbohydrates with digestion characteristics between those of lente uncooked starches and rapidly digestible oligosaccharides were administered in a dose of 1.5 g/kg body weight to five patients with glycogenosis from glucose-6-phosphatase deficiency. Postprandial duration of normoglycemia and concentrations of blood insulin and lactate were determined. Uncooked barley groats in water, or incorporated in a meal turned out to behave as lente carbohydrates. Uncooked couscous in water, couscous incorporated in a meal, and partially cooked macaroni given as a meal behaved as semilente carbohydrates as compared with uncooked cornstarch and glucose. The in vitro determination of the digestibility index along with the in vivo tolerance test enables us to choose and incorporate semilente carbohydrates in the day-time treatment of patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3291600     DOI: 10.1093/ajcn/48.1.95

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  7 in total

1.  Oral cornstarch therapy: is persorption harmless?

Authors:  R Gitzelmann; M A Spycher
Journal:  Eur J Pediatr       Date:  1993-07       Impact factor: 3.183

2.  Adeno-associated virus-mediated correction of a canine model of glycogen storage disease type Ia.

Authors:  David A Weinstein; Catherine E Correia; Thomas Conlon; Andrew Specht; John Verstegen; Karine Onclin-Verstegen; Martha Campbell-Thompson; Gurmeet Dhaliwal; Layla Mirian; Holly Cossette; Darin J Falk; Sean Germain; Nathalie Clement; Stacy Porvasnik; Laurie Fiske; Maggie Struck; Harvey E Ramirez; Juan Jordan; Karl Andrutis; Janice Y Chou; Barry J Byrne; Cathryn S Mah
Journal:  Hum Gene Ther       Date:  2010-07       Impact factor: 5.695

3.  Use of modified cornstarch therapy to extend fasting in glycogen storage disease types Ia and Ib.

Authors:  Catherine E Correia; Kaustuv Bhattacharya; Philip J Lee; Jonathan J Shuster; Douglas W Theriaque; Meena N Shankar; G Peter A Smit; David A Weinstein
Journal:  Am J Clin Nutr       Date:  2008-11       Impact factor: 7.045

4.  A novel starch for the treatment of glycogen storage diseases.

Authors:  K Bhattacharya; R C Orton; X Qi; H Mundy; D W Morley; M P Champion; S Eaton; R F Tester; P J Lee
Journal:  J Inherit Metab Dis       Date:  2007-05-19       Impact factor: 4.982

5.  Effects of cornstarch treatment in very young children with type I glycogen storage disease.

Authors:  M Hayde; K Widhalm
Journal:  Eur J Pediatr       Date:  1990-06       Impact factor: 3.183

Review 6.  Glycogen storage disease type Ia in canines: a model for human metabolic and genetic liver disease.

Authors:  Andrew Specht; Laurie Fiske; Kirsten Erger; Travis Cossette; John Verstegen; Martha Campbell-Thompson; Maggie B Struck; Young Mok Lee; Janice Y Chou; Barry J Byrne; Catherine E Correia; Cathryn S Mah; David A Weinstein; Thomas J Conlon
Journal:  J Biomed Biotechnol       Date:  2011-01-03

7.  A pilot longitudinal study of the use of waxy maize heat modified starch in the treatment of adults with glycogen storage disease type I: a randomized double-blind cross-over study.

Authors:  Kaustuv Bhattacharya; Helen Mundy; Maggie F Lilburn; Michael P Champion; David W Morley; François Maillot
Journal:  Orphanet J Rare Dis       Date:  2015-02-15       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.